168 related articles for article (PubMed ID: 23059768)
1. Longitudinal analysis of maternal plasma apolipoproteins in pregnancy: a targeted proteomics approach.
Flood-Nichols SK; Tinnemore D; Wingerd MA; Abu-Alya AI; Napolitano PG; Stallings JD; Ippolito DL
Mol Cell Proteomics; 2013 Jan; 12(1):55-64. PubMed ID: 23059768
[TBL] [Abstract][Full Text] [Related]
2. Protein expression profiling reveals distinctive changes in serum proteins associated with chronic pancreatitis.
Hartmann D; Felix K; Ehmann M; Schnölzer M; Fiedler S; Bogumil R; Büchler M; Friess H
Pancreas; 2007 Nov; 35(4):334-42. PubMed ID: 18090239
[TBL] [Abstract][Full Text] [Related]
3. Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.
Karlsson H; Leanderson P; Tagesson C; Lindahl M
Proteomics; 2005 Feb; 5(2):551-65. PubMed ID: 15627967
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein Profiles in Very Preterm and Term-Born Preschool Children.
Posod A; Pechlaner R; Yin X; Burnap SA; Kiechl SJ; Willeit J; Witztum JL; Mayr M; Kiechl S; Kiechl-Kohlendorfer U
J Am Heart Assoc; 2019 Apr; 8(8):e011199. PubMed ID: 30968745
[TBL] [Abstract][Full Text] [Related]
5. Development of multiplex mass spectrometric immunoassay for detection and quantification of apolipoproteins C-I, C-II, C-III and their proteoforms.
Trenchevska O; Schaab MR; Nelson RW; Nedelkov D
Methods; 2015 Jun; 81():86-92. PubMed ID: 25752847
[TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
7. Proteoform profiling of peripheral blood serum proteins from pregnant women provides a molecular IUGR signature.
Wölter M; Röwer C; Koy C; Rath W; Pecks U; Glocker MO
J Proteomics; 2016 Oct; 149():44-52. PubMed ID: 27109350
[TBL] [Abstract][Full Text] [Related]
8. Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.
Karlsson H; Leanderson P; Tagesson C; Lindahl M
Proteomics; 2005 Apr; 5(5):1431-45. PubMed ID: 15761960
[TBL] [Abstract][Full Text] [Related]
9. Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.
Cohen M; Yossef R; Erez T; Kugel A; Welt M; Karpasas MM; Bones J; Rudd PM; Taieb J; Boissin H; Harats D; Noy K; Tekoah Y; Lichtenstein RG; Rubin E; Porgador A
PLoS One; 2011 Jan; 6(1):e14540. PubMed ID: 21267442
[TBL] [Abstract][Full Text] [Related]
10. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.
Briones ER; Mao SJ; Palumbo PJ; O'Fallon WM; Chenoweth W; Kottke BA
Metabolism; 1984 Jan; 33(1):42-9. PubMed ID: 6419012
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein and lipid abnormalities in uremic children on hemodialysis.
Ohta T; Matsuda I
Clin Chim Acta; 1985 Apr; 147(2):145-54. PubMed ID: 3921292
[TBL] [Abstract][Full Text] [Related]
12. Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay.
Song Z; Dong R; Fan Y; Zheng S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):370-5. PubMed ID: 22569524
[TBL] [Abstract][Full Text] [Related]
13. Plasma apolipoprotein A-I, A-II, B, E and C-III containing particles in men with premature coronary artery disease.
Genest JJ; Bard JM; Fruchart JC; Ordovas JM; Wilson PF; Schaefer EJ
Atherosclerosis; 1991 Oct; 90(2-3):149-57. PubMed ID: 1684707
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry.
Lin CH; Su H; Hung CC; Lane HY; Shiea J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361610
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
Breckenridge WC; Alaupovic P; Cox DW; Little JA
Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteomic biomarkers in maternal plasma in the early second trimester that predict the subsequent development of gestational diabetes.
Kim SM; Park JS; Norwitz ER; Lee SM; Kim BJ; Park CW; Jun JK; Kim CW; Syn HC
Reprod Sci; 2012 Feb; 19(2):202-9. PubMed ID: 22101237
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences.
Noma A; Hata Y; Goto Y
Clin Chim Acta; 1991 Jun; 199(2):147-57. PubMed ID: 1908362
[TBL] [Abstract][Full Text] [Related]
18. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
19. Isoforms of rat apolipoproteins and changes induced by insulin deficiency and fasting.
Callow MJ; Redgrave TG
Biochim Biophys Acta; 1993 Jul; 1168(3):271-9. PubMed ID: 8323966
[TBL] [Abstract][Full Text] [Related]
20. Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages.
Zannis VI; Cole FS; Jackson CL; Kurnit DM; Karathanasis SK
Biochemistry; 1985 Jul; 24(16):4450-5. PubMed ID: 3931677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]